bs-0481R [Primary Antibody]
IFN gamma Polyclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: IFN gamma

Immunogen Range: 81-166/166


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 3458

Swiss Prot: P01579

Source: KLH conjugated synthetic peptide derived from human IFN Gamma

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Background:

Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons.

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
ELISA(1:500-1000)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Predicted Molecular Weight: 15


Cross Reactive Species: Human

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Nimmagadda, Vamshi K., et al. "Overexpression of SIRT1 Protein in Neurons Protects against Experimental Autoimmune Encephalomyelitis through Activation of Multiple SIRT1 Targets." The Journal of Immunology (2013).Read more>>
  • Guo, Jie, Jiang Qian, and Rui Zhang. "Histopathology and immunohistochemical profile in idiopathic dacryoadenitis." Current Eye Research 37.5 (2012): 365-371.Read more>>
  • Wang, Lu, et al. "Deficiency of interferon-gamma or its receptor promotes colorectal cancer development." Journal of Interferon & Cytokine Research 35.4 (2015): 273-280.Read more>>
  • Liang Wang et al. Clinical Significance of M1/M2 Macrophages and Related Cytokines in Patients with Spinal Tuberculosis. Dis Markers. 2020 May 20;2020:2509454.Read more>>
  • Xiaoqian Shang. et al. Diagnostic value of CXCR3 and its ligands in spinal tuberculosis. Exp Ther Med. 2021 Jan;21(1):1-1Read more>>
  • Louis Boafo Kwantwi. et al. Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer. Bioengineered. 2021;12(1):6996-7006Read more>>
  • Hanrui Liu. et al. Structural Variability of Lipoarabinomannan Modulates Innate Immune Responses within Infected Alveolar Epithelial Cells. Cells-Basel. 2022 Jan;11(3):361Read more>>
  • Xiaoliang Hua. et al. CXCR3 antagonist AMG487 ameliorates experimental autoimmune prostatitis by diminishing Th1 cell differentiation and inhibiting macrophage M1 phenotypic activation. PROSTATE. 2022 Jun 14Read more>>
  • He Yangsong. et al. Multi-perspective comparison of the immune microenvironment of primary colorectal cancer and liver metastases. J TRANSL MED. 2022 Dec;20(1):1-13Read more>>
  • Linghong Huang. et al. Natural blood plasma-based hydrogels as tumor vaccines delivery systems to enhance biomimetic recruitment of antigen presenting cells for tumor immunotherapy. MATER TODAY BIO. 2022 Dec;17:100497Read more>>
  • Yanan Hao. et al. Alginate Oligosaccharides Repair Liver Injury by Improving Anti-Inflammatory Capacity in a Busulfan-Induced Mouse Model. INT J MOL SCI. 2023 Jan;24(4):3097Read more>>
  • Jieling Zheng. et al. Microwave-Responsive Edge-Oxidized Graphene for Imaging-Guided Neoadjuvant Thermal Immunotherapy via Promoting Immunogenic Cell Death and Redressing Hypoxia. ACS APPL NANO MATER. 2024;XXXX(XXX):XXX-XXXRead more>>
  • Wang Xiao. et al. The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy. PARASITE VECTOR. 2024 Dec;17(1):1-13Read more>>
VALIDATION IMAGES

Formalin-fixed and paraffin-embedded human kidney tissue labeled with Rabbit Anti- IFN-gamma \nPolyclonal Antibody, Unconjugated (bs-0481R) at 1:200 followed by conjugation to the secondary \nantibody and DAB staining


HL-60 lysates probed with IFN gamma Polyclonal Antibody, Unconjugated (bs-0481R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.


Molt-4 lysates probed with IFN gamma Polyclonal Antibody, Unconjugated (bs-0481R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.